Foghorn Therapeutics Inc. announced the appointment of Ian Smith to its Board of Directors effective, April 27. Mr. Smith is currently the Executive Chairperson of Viacyte Inc. He was previously Chief Operating Officer at Vertex Pharmaceuticals Inc. Prior to joining Vertex in 2001, Mr. Smith served as a partner in the Life Science and Technology Practice of the accounting firm Ernst & Young LLP. He also serves as Chairman of the Board of Solid Biosciences, as a board member of AavantiBio Inc., and as a Senior Advisor to Bain Capital Life Sciences.